
|Articles|July 11, 2012
Cost Implications of Pertuzumab/Trastuzumab Combination
In this segment, panelists address coverage strategies health plans may utilize to finance patient access to the combination treatment.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
AbbVie Joins Trump Drug Pricing Effort, Pledges $100B in US R&D Investment
2
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
3
Managed Care Cast News Roundup: January 13, 2026
4
Rural Hospital Closures Tied to Improved Cancer Surgery Outcomes
5




























































